CXCL13 and neoplasm: While CXCL13‐overexpression did not significantly alter CAR T cell accumulation in the spleen (Figure 5k), it markedly enhanced CAR T cell infiltration into both the tumor‐draining lymph nodes (Figure 5l) and tumor sites (Figure 5m).